P
Pathomiq develops AI models utilizing a proprietary deep tissue phenotype library derived from extensive cancer pathology data. This technology predicts patient outcomes, treatment response, and identifies novel biomarkers for precision medicine applications. The platform accelerates clinical trials through guided patient selection, improving therapeutic efficacy in oncology.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Pathomiq develops AI models utilizing a proprietary deep tissue phenotype library derived from extensive cancer pathology data. This technology predicts patient outcomes, treatment response, and identifies novel biomarkers for precision medicine applications. The platform accelerates clinical trials through guided patient selection, improving therapeutic efficacy in oncology.